-
Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
Study
EGAS00001004353
-
Whole-exome sequencing of extranodal NK/T cell lymphoma
Study
EGAS00001004357
-
Whole genome sequencing of glioblastoma reveals enrichment of non-coding constraint mutations in known and novel genes
Study
EGAS00001004379
-
Bulk RNAseq gene expression of baseline tumors from metastatic urothelial bladder cancer patients (IMvigor210) and metastatic renal cell carcinoma (IMmotion150)
Study
EGAS00001004386
-
Whole exome sequencing (bam files) of 55 samples of myxofibrosarcoma and 44 matched pairs
Study
EGAS00001005442
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
Initial whole genome sequencing of plasma cell neoplasms in First Responders exposed to the World Trade Center attack of September 11, 2001
Study
EGAS00001004467
-
Transcriptomic analysis of the Phase 3 COMPARZ clinical trial
Study
EGAS00001004534
-
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients with Advanced Lung Adenocarcinoma
Study
EGAS00001004546
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551